EU reviewing MSD’s Keytruda/chemo combo
admin 24th April 2018 Uncategorised 0European regulators have kicked off a review of MSD’s Keytruda/pemetrexed combination for the first-line treatment of patients with metastatic nonsquamous non-small cell lung cancer (NSCLC).
More: EU reviewing MSD’s Keytruda/chemo combo
Source: News